help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berger, U.
Right arrow Articles by Coombes, R. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berger, U.
Right arrow Articles by Coombes, R. C.

Journal of Clinical Endocrinology & Metabolism, Vol 67, 607-613, Copyright © 1988 by Endocrine Society


ARTICLES

Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues

U Berger, P Wilson, RA McClelland, K Colston, MR Haussler, JW Pike and RC Coombes
Ludwig Institute for Cancer Research, St. George's Hospital Medical School, London, United Kingdom.

We developed an immunocytochemical technique to visualize the receptors for 1,25-dihydroxyvitamin D [1,25-(OH)2D receptor] in cryostat sections of normal human tissues, using a rat monoclonal antibody (9A7 gamma) to the chick intestinal receptor, which has been found to react with mammalian 1,25-(OH)2D receptors. Localization of the antigen was predominantly nuclear, with little cytoplasmic immunoreactivity. Specific staining was seen in the nuclei of many normal epithelial tissues, including liver, kidney, thyroid, adrenal, gastrointestinal tract, breast, and skin. No nuclear staining was seen when tissue sections were incubated with normal rat immunoglobulin G or when the monoclonal antibody was preincubated with a receptor-enriched chick intestinal cytosol preparation. Our results demonstrate that the receptor for 1,25-(OH)2D is localized in the nucleus and widely distributed in normal human tissues.


This article has been cited by other articles:


Home page
Reproductive SciencesHome page
A. Agic, Hong Xu, C. Altgassen, F. Noack, M. M. Wolfler, K. Diedrich, M. Friedrich, R. N. Taylor, and D. Hornung
Relative Expression of 1,25-Dihydroxyvitamin D3 Receptor, Vitamin D 1{alpha}-Hydroxylase, Vitamin D 24-Hydroxylase, and Vitamin D 25-Hydroxylase in Endometriosis and Gynecologic Cancers
Reproductive Sciences, July 1, 2007; 14(5): 486 - 497.
[Abstract] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
W. Y. Chen, E. R. Bertone-Johnson, D. J. Hunter, W. C. Willett, and S. E. Hankinson
Associations Between Polymorphisms in the Vitamin D Receptor and Breast Cancer Risk
Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2335 - 2339.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
R. Adachi, Y. Honma, H. Masuno, K. Kawana, I. Shimomura, S. Yamada, and M. Makishima
Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative
J. Lipid Res., January 1, 2005; 46(1): 46 - 57.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
T. M. Beer and A. Myrthue
Calcitriol in cancer treatment: From the lab to the clinic
Mol. Cancer Ther., March 1, 2004; 3(3): 373 - 381.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J.-C. Hsieh, J. M. Sisk, P. W. Jurutka, C. A. Haussler, S. A. Slater, M. R. Haussler, and C. C. Thompson
Physical and Functional Interaction between the Vitamin D Receptor and Hairless Corepressor, Two Proteins Required for Hair Cycling
J. Biol. Chem., October 3, 2003; 278(40): 38665 - 38674.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. M. Peehl, A. V. Krishnan, and D. Feldman
Pathways Mediating the Growth-Inhibitory Actions of Vitamin D in Prostate Cancer
J. Nutr., July 1, 2003; 133(7): 2461S - 2469.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. Liu, K. Oettel, G. Ripple, M. J. Staab, D. Horvath, D. Alberti, R. Arzoomanian, R. Marnocha, R. Bruskewitz, R. Mazess, et al.
Phase I Trial of 1{alpha}-Hydroxyvitamin D2 in Patients with Hormone Refractory Prostate Cancer
Clin. Cancer Res., September 1, 2002; 8(9): 2820 - 2827.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Drocourt, J.-C. Ourlin, J.-M. Pascussi, P. Maurel, and M.-J. Vilarem
Expression of CYP3A4, CYP2B6, and CYP2C9 Is Regulated by the Vitamin D Receptor Pathway in Primary Human Hepatocytes
J. Biol. Chem., July 5, 2002; 277(28): 25125 - 25132.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. E. Thummel, C. Brimer, K. Yasuda, J. Thottassery, T. Senn, Y. Lin, H. Ishizuka, E. Kharasch, J. Schuetz, and E. Schuetz
Transcriptional Control of Intestinal Cytochrome P-4503A by 1alpha ,25-Dihydroxy Vitamin D3
Mol. Pharmacol., December 1, 2001; 60(6): 1399 - 1406.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
P. Schmiedlin-Ren, K. E. Thummel, J. M. Fisher, M. F. Paine, and P. B. Watkins
Induction of CYP3A4 by 1alpha ,25-Dihydroxyvitamin D3 Is Human Cell Line-Specific and Is Unlikely to Involve Pregnane X Receptor
Drug Metab. Dispos., November 1, 2001; 29(11): 1446 - 1453.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Masood, S. Nagpal, T. Zheng, J. Cai, A. Tulpule, D. L. Smith, and P. S. Gill
Kaposi sarcoma is a therapeutic target for vitamin D3 receptor agonist
Blood, November 1, 2000; 96(9): 3188 - 3194.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. D. Díaz, C. Paraskeva, M. G. Thomas, L. Binderup, and A. Hague
Apoptosis Is Induced by the Active Metabolite of Vitamin D3 and Its Analogue EB1089 in Colorectal Adenoma and Carcinoma Cells: Possible Implications for Prevention and Therapy
Cancer Res., April 1, 2000; 60(8): 2304 - 2312.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
X.-Y. Li, M. Boudjelal, J.-H. Xiao, Z.-H. Peng, A. Asuru, S. Kang, G. J. Fisher, and J. J. Voorhees
1,25-Dihydroxyvitamin D3 Increases Nuclear Vitamin D3 Receptors by Blocking Ubiquitin/Proteasome-Mediated Degradation in Human Skin
Mol. Endocrinol., October 1, 1999; 13(10): 1686 - 1694.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. J. Brown, A. Dusso, and E. Slatopolsky
Vitamin D
Am J Physiol Renal Physiol, August 1, 1999; 277(2): F157 - F175.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Reichrath, J. Kamradt, X. Hong Zhu, X. Fu Kong, W. Tilgen, and M. F. Holick
Analysis of 1,25-Dihydroxyvitamin D3 Receptors (VDR) in Basal Cell Carcinomas
Am. J. Pathol., August 1, 1999; 155(2): 583 - 589.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. J. Malloy, J. W. Pike, and D. Feldman
The Vitamin D Receptor and the Syndrome of Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets
Endocr. Rev., April 1, 1999; 20(2): 156 - 188.
[Abstract] [Full Text]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
B. L. Lokeshwar, G. G. Schwartz, M. G. Selzer, K. L. Burnstein, S.-H. Zhuang, N. L. Block, and L. Binderup
Inhibition of Prostate Cancer Metastasis in Vivo: A Comparison of 1,25-Dihydroxyvitamin D (Calcitriol) and EB1089
Cancer Epidemiol. Biomarkers Prev., March 1, 1999; 8(3): 241 - 248.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Romagnolo, F. Cluzeaud, M. Lambert, S. Colnot, A. Porteu, T. Molina, M. Tomasset, A. Vandewalle, A. Kahn, and C. Perret
Tissue-specific and Hormonal Regulation of Calbindin-D9K Fusion Genes in Transgenic Mice
J. Biol. Chem., July 12, 1996; 271(28): 16820 - 16826.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1988 by The Endocrine Society